Cargando…

Identification of MAP kinase pathways as therapeutic targets in gallbladder carcinoma using targeted parallel sequencing

The aim of this study was to profile somatic mutation spectrum in gallbladder cancers (GBCs), and determine the role of MAP kinase pathway in GBC by a series of in vitro and in vivo studies. We performed targeted massively parallel sequencing of DNA isolated from GBCs and matched blood from 14 GBC p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Mengdan, Chen, Lihong, Qu, Yiping, Sui, Fang, Yang, Qi, Ji, Meiju, Shi, Bingyin, Chen, Mingwei, Hou, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482657/ https://www.ncbi.nlm.nih.gov/pubmed/28422736 http://dx.doi.org/10.18632/oncotarget.16751

Ejemplares similares

Genomic copy number gains of ErbB family members predict poor clinical outcomes in glioma patients
por: Liu, Rui, et al.
Publicado: (2017)

Increased expression of EHF via gene amplification contributes to the activation of HER family signaling and associates with poor survival in gastric cancer
por: Shi, Jing, et al.
Publicado: (2016)

c-Myc is Required for BRAF(V600E)-Induced Epigenetic Silencing by H3K27me3 in Tumorigenesis
por: Qu, Yiping, et al.
Publicado: (2017)

ACYP2 contributes to malignant progression of glioma through promoting Ca(2+) efflux and subsequently activating c-Myc and STAT3 signals
por: Li, Mengdan, et al.
Publicado: (2020)

Low copy number of mitochondrial DNA (mtDNA) predicts worse prognosis in early-stage laryngeal cancer patients
por: Dang, Siwen, et al.
Publicado: (2014)

TERT promoter mutations and long telomere length predict poor survival and radiotherapy resistance in gliomas
por: Gao, Ke, et al.
Publicado: (2015)

Aberrant DNA methylation of drug metabolism and transport genes in nodular goiter
por: Zhang, Lihong, et al.
Publicado: (2011)

Identification of Direct Target Engagement Biomarkers for Kinase-Targeted Therapeutics
por: Paweletz, Cloud P., et al.
Publicado: (2011)

Parallel Analysis of 124 Universal SNPs for Human Identification by Targeted Semiconductor Sequencing
por: Zhang, Suhua, et al.
Publicado: (2015)

CEP55 as a promising biomarker and therapeutic target on gallbladder cancer
por: Huang, Maotuan, et al.
Publicado: (2023)

MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6
por: Shao, Yuan, et al.
Publicado: (2013)

Emerging role of MAP kinase pathways as therapeutic targets in COPD
por: Mercer, Becky A, et al.
Publicado: (2006)

Association of promoter methylation with histologic type and pleural indentation in non-small cell lung cancer (NSCLC)
por: Ji, Meiju, et al.
Publicado: (2011)

Parthenolide Inhibits STAT3 Signaling by Covalently Targeting Janus Kinases
por: Liu, Man, et al.
Publicado: (2018)

Increased expression of NAF1 contributes to malignant phenotypes of glioma cells through promoting protein synthesis and associates with poor patient survival
por: Wei, Jing, et al.
Publicado: (2019)

PAX3 is a novel tumor suppressor by regulating the activities of major signaling pathways and transcription factor FOXO3a in thyroid cancer
por: Liu, Wei, et al.
Publicado: (2016)

Identification of a germline CSPG4 variation in a family with neurofibromatosis type 1-like phenotype
por: Bai, Zhuanli, et al.
Publicado: (2021)

Highly frequent promoter methylation and PIK3CA amplification in non-small cell lung cancer (NSCLC)
por: Ji, Meiju, et al.
Publicado: (2011)

Increased expression of EHF contributes to thyroid tumorigenesis through transcriptionally regulating HER2 and HER3
por: Lv, Yanyan, et al.
Publicado: (2016)

Macrophage migration inhibitory factor - a therapeutic target in gallbladder cancer
por: Subbannayya, Tejaswini, et al.
Publicado: (2015)

Hedgehog signaling pathway is a potential therapeutic target for gallbladder cancer
por: Matsushita, Shojiro, et al.
Publicado: (2014)

Increased copy number of mitochondrial DNA predicts poor prognosis of esophageal squamous cell carcinoma
por: Li, Heng, et al.
Publicado: (2018)

CD73 and PD-L1 as Potential Therapeutic Targets in Gallbladder Cancer
por: Cao, Lu, et al.
Publicado: (2022)

Sphingosine kinase 1 as an anticancer therapeutic target
por: Gao, Ying, et al.
Publicado: (2015)

Variable copy number of mitochondrial DNA (mtDNA) predicts worse prognosis in advanced gastric cancer patients
por: Zhang, Guanjun, et al.
Publicado: (2013)

Identification of anaplastic lymphoma kinase as a potential therapeutic target in Basal Cell Carcinoma
por: Ning, Hanna, et al.
Publicado: (2013)

Sulforaphane inhibits thyroid cancer cell growth and invasiveness through the reactive oxygen species-dependent pathway
por: Wang, Liping, et al.
Publicado: (2015)

Atovaquone-HSA nano-drugs enhance the efficacy of PD-1 blockade immunotherapy by alleviating hypoxic tumor microenvironment
por: Wang, Simeng, et al.
Publicado: (2021)

Identification of therapeutic targets in ovarian cancer through active tyrosine kinase profiling
por: Montero, Juan Carlos, et al.
Publicado: (2015)

Identification of polo‐like kinase 1 as a therapeutic target in murine lupus
por: Li, Yaxi, et al.
Publicado: (2022)

Bortezomib‐Encapsulated Dual Responsive Copolymeric Nanoparticles for Gallbladder Cancer Targeted Therapy
por: Chen, Mingyu, et al.
Publicado: (2022)

Lenvatinib induces anticancer activity in gallbladder cancer by targeting AKT
por: Ye, Jianwen, et al.
Publicado: (2021)

Overview of current targeted therapy in gallbladder cancer
por: Song, Xiaoling, et al.
Publicado: (2020)

Identification of Differentially Expressed Kinase and Screening Potential Anticancer Drugs in Papillary Thyroid Carcinoma
por: Zhang, Huairong, et al.
Publicado: (2016)

Crowdsourced mapping of unexplored target space of kinase inhibitors
por: Cichońska, Anna, et al.
Publicado: (2021)

Disulfiram/Cu Kills and Sensitizes BRAF-Mutant Thyroid Cancer Cells to BRAF Kinase Inhibitor by ROS-Dependently Relieving Feedback Activation of MAPK/ERK and PI3K/AKT Pathways
por: Xie, Jingyi, et al.
Publicado: (2023)

Association of METS-IR index with prevalence of gallbladder stones and the age at the first gallbladder stone surgery in US adults: A cross-sectional study
por: Wang, Jin, et al.
Publicado: (2022)

PIM kinases as therapeutic targets against advanced melanoma
por: Shannan, Batool, et al.
Publicado: (2016)

Receptor Tyrosine Kinases as Therapeutic Targets in Rhabdomyosarcoma
por: Crose, Lisa E. S., et al.
Publicado: (2011)

Therapeutic targeting of transcriptional cyclin-dependent kinases
por: Galbraith, Matthew D., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_k5qnud2tn638no98qs0ib3cpr2